These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22450695)

  • 1. Completion potentials of sufficient component causes.
    Lee WC
    Epidemiology; 2012 May; 23(3):446-53. PubMed ID: 22450695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weighing the causal pies in case-control studies.
    Liao SF; Lee WC
    Ann Epidemiol; 2010 Jul; 20(7):568-73. PubMed ID: 20538201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the proportion of disease due to classes of sufficient causes.
    Hoffmann K; Heidemann C; Weikert C; Schulze MB; Boeing H
    Am J Epidemiol; 2006 Jan; 163(1):76-83. PubMed ID: 16293718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the relations between excess fraction, attributable fraction, and etiologic fraction.
    Suzuki E; Yamamoto E; Tsuda T
    Am J Epidemiol; 2012 Mar; 175(6):567-75. PubMed ID: 22343634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causal models in epidemiology: past inheritance and genetic future.
    Vineis P; Kriebel D
    Environ Health; 2006 Jul; 5():21. PubMed ID: 16859537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure-time-varying hazard function ratios in case-control studies of drug effects.
    Guess HA
    Pharmacoepidemiol Drug Saf; 2006 Feb; 15(2):81-92. PubMed ID: 16287211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Roaming through methodology. IV. Causality].
    van Gijn J; Rooijmans HG
    Ned Tijdschr Geneeskd; 1998 Aug; 142(31):1765-7. PubMed ID: 9856141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The case-cohort design in outbreak investigations.
    Le Polain de Waroux O; Maguire H; Moren A
    Euro Surveill; 2012 Jun; 17(25):. PubMed ID: 22748005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties of 2 counterfactual effect definitions of a point exposure.
    Flanders WD; Klein M
    Epidemiology; 2007 Jul; 18(4):453-60. PubMed ID: 17473709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A competing risks approach to "biologic" interaction.
    Andersen PK; Skrondal A
    Lifetime Data Anal; 2015 Apr; 21(2):300-14. PubMed ID: 25613424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attributable risk function in the proportional hazards model for censored time-to-event.
    Chen YQ; Hu C; Wang Y
    Biostatistics; 2006 Oct; 7(4):515-29. PubMed ID: 16478758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to deal with measures of association: a short guide for the clinician.
    Knol MJ; Algra A; Groenwold RH
    Cerebrovasc Dis; 2012; 33(2):98-103. PubMed ID: 22156574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct and indirect effects in a survival context.
    Lange T; Hansen JV
    Epidemiology; 2011 Jul; 22(4):575-81. PubMed ID: 21552129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of selected causality theories].
    Thoemmes F
    Gesundheitswesen; 2011 Dec; 73(12):880-3. PubMed ID: 22193896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysing and interpreting competing risk data.
    Pintilie M
    Stat Med; 2007 Mar; 26(6):1360-7. PubMed ID: 16900575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A proposed clinical and biological interpretation of mediated interaction.
    Ikram MA; VanderWeele TJ
    Eur J Epidemiol; 2015 Oct; 30(10):1115-8. PubMed ID: 26438385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case-cohort designs and analysis for clustered failure time data.
    Lu SE; Shih JH
    Biometrics; 2006 Dec; 62(4):1138-48. PubMed ID: 17156289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifiability of causal effects for binary variables with baseline data missing due to death.
    Yan W; Hu Y; Geng Z
    Biometrics; 2012 Mar; 68(1):121-8. PubMed ID: 21838813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cause-specific cumulative incidence estimation and the fine and gray model under both left truncation and right censoring.
    Geskus RB
    Biometrics; 2011 Mar; 67(1):39-49. PubMed ID: 20377575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Test for additive interaction in proportional hazards models.
    Li R; Chambless L
    Ann Epidemiol; 2007 Mar; 17(3):227-36. PubMed ID: 17320789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.